AGP Picks
View all

Personal Wealth Guide: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Personal Wealth Guide.

Press releases published on November 9, 2026

Transgene Reports Continued Clinical Progress  and Q3 2026 Financial Update
Transgene poursuit ses programmes cliniques et fait le point sur sa situation financière au troisième trimestre 2026
Niki BioSolutions Announces Presentation at the Clinical Trials on Alzheimer’s Disease (CTAD) 2026 Conference
Dresser Utility Solutions Completes RMG Acquisition
ArcelorMittal announces Brad Davey to retire on 1st January 2027
Space and Time Enterprise Brings Privacy and Verifiable Data to AI Applications
Colossal Honored as a Gold Winner in Fundraising Campaign, Education, Art & Culture for the 6th Annual Anthem Awards
FINAL RESULTS OF THE REOPENING OF THE TERMS: OFFEROR REACHED A SHAREHOLDING OF APPROXIMATELY 96.25% OF THE ISSUER'S COMMON SHARE CAPITAL
Lendmark Financial Services and Thrillworks Honored with 2026 Silver W3 Award from the Academy of Interactive and Visual Arts
Stanford Medicine Sutter Health Cancer Center expands access to advanced cancer care in the East Bay
From Writing Code to Running Agents: WeAreDevelopers Unveils the Program for Its First Conference in India
Solomon Global Offers Exclusive Signed Una and the Lion 2027 Gold Bullion Coins
2026 state mental health rankings released by Mental Health America
Popcorn Company Parodies Elizabeth Holmes' Iconic Photo in Viral X Ad, Helping Surpass $1 Million Fundraising Goal
Silvercrest Asset Management Group Ranked #8 in Nasdaq eVestment’s Q3 2026 Brand Awareness Rankings Among Consultants and Asset Owners in the Mid-Sized Firm Peer Universe
National Advertising Division Found Unilever’s Dove Deep Moisture Body Wash Claims Supported
Kraig Labs Ships Spider Silk to Developers Across Global Industries
Partners for Affordable Housing kicks off national campaign to address the housing crisis, deploying nearly $1 million to 10 nonprofits across Canada
Zealand Pharma announces Boehringer Ingelheim’s survodutide is the first glucagon/GLP-1 dual agonist to demonstrate a favorable cardiovascular safety profile in global Phase 3 SYNCHRONIZE-CVOT trial with significant cardiometabolic benefits
Texas Capital Bancshares, Inc. Begins Trading on TXSE Under New TXCP Ticker

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Personal Wealth Guide

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.